Literature DB >> 26100627

Novel Allosteric Modulators of G Protein-coupled Receptors.

Patrick R Gentry1, Patrick M Sexton1, Arthur Christopoulos2.   

Abstract

G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topographically distinct, yet conformationally linked, domains. Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chemical probes due to the potential for novel therapeutics. It is now apparent that some GPCRs possess more than one targetable allosteric site, in addition to a growing list of putative endogenous modulators. Advances in structural biology are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biological characterization.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein; G protein-coupled receptor (GPCR); allosteric regulation; biased agonism; bitopic ligand; chemical biology; drug discovery; structural biology

Mesh:

Substances:

Year:  2015        PMID: 26100627      PMCID: PMC4528113          DOI: 10.1074/jbc.R115.662759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

Review 1.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

2.  Advancing the drug discovery and development process.

Authors:  K C Nicolaou
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-13       Impact factor: 15.336

3.  Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.

Authors:  Celine Valant; Lauren T May; Luigi Aurelio; Chung Hui Chuo; Paul J White; Jo-Anne Baltos; Patrick M Sexton; Peter J Scammells; Arthur Christopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-11       Impact factor: 11.205

4.  A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Authors:  Desu Chen; Jiayu Liao; Na Li; Caihong Zhou; Qing Liu; Guangxing Wang; Rui Zhang; Song Zhang; Lilin Lin; Kaixian Chen; Xin Xie; Fajun Nan; Andrew A Young; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

5.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

6.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.

Authors:  J Proska; S Tucek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

7.  A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.

Authors:  Tod Steinfeld; Mathai Mammen; Jacqueline A M Smith; Richard D Wilson; Jeffrey R Jasper
Journal:  Mol Pharmacol       Date:  2007-05-03       Impact factor: 4.436

8.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

9.  Pharmacological folding chaperones act as allosteric ligands of Frizzled4.

Authors:  Serena F Generoso; Mariateresa Giustiniano; Giuseppe La Regina; Sara Bottone; Sara Passacantilli; Salvatore Di Maro; Hilde Cassese; Agostino Bruno; Massimo Mallardo; Monica Dentice; Romano Silvestri; Luciana Marinelli; Daniela Sarnataro; Stefano Bonatti; Ettore Novellino; Mariano Stornaiuolo
Journal:  Nat Chem Biol       Date:  2015-03-09       Impact factor: 15.040

10.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  60 in total

1.  Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.

Authors:  Kathy Sengmany; Junaid Singh; Gregory D Stewart; P Jeffrey Conn; Arthur Christopoulos; Karen J Gregory
Journal:  Neuropharmacology       Date:  2016-07-05       Impact factor: 5.250

2.  Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro.

Authors:  Susanne Neumann; Elena Eliseeva; Alisa Boutin; Elena Barnaeva; Marc Ferrer; Noel Southall; David Kim; Xin Hu; Sarah J Morgan; Juan J Marugan; Marvin C Gershengorn
Journal:  J Pharmacol Exp Ther       Date:  2017-10-31       Impact factor: 4.030

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

Review 5.  Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.

Authors:  Leepakshi Khurana; Ken Mackie; Daniele Piomelli; Debra A Kendall
Journal:  Neuropharmacology       Date:  2017-05-17       Impact factor: 5.250

Review 6.  Emerging structural biology of lipid G protein-coupled receptors.

Authors:  Martin Audet; Raymond C Stevens
Journal:  Protein Sci       Date:  2019-02       Impact factor: 6.725

7.  Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites.

Authors:  Kathryn D Luderman; Jennie L Conroy; R Benjamin Free; Noel Southall; Marc Ferrer; Marta Sanchez-Soto; Amy E Moritz; Blair K A Willette; Tim J Fyfe; Prashi Jain; Steve Titus; Lisa A Hazelwood; Jeffrey Aubé; J Robert Lane; Kevin J Frankowski; David R Sibley
Journal:  Mol Pharmacol       Date:  2018-08-01       Impact factor: 4.436

8.  Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).

Authors:  Vivek Kumar; Amy E Moritz; Thomas M Keck; Alessandro Bonifazi; Michael P Ellenberger; Christopher D Sibley; R Benjamin Free; Lei Shi; J Robert Lane; David R Sibley; Amy Hauck Newman
Journal:  J Med Chem       Date:  2017-02-10       Impact factor: 7.446

9.  Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.

Authors:  Robert B Laprairie; Abhijit R Kulkarni; Pushkar M Kulkarni; Dow P Hurst; Diane Lynch; Patricia H Reggio; David R Janero; Roger G Pertwee; Lesley A Stevenson; Melanie E M Kelly; Eileen M Denovan-Wright; Ganesh A Thakur
Journal:  ACS Chem Neurosci       Date:  2016-04-25       Impact factor: 4.418

Review 10.  Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

Authors:  Dennis J Sholler; Marilyn A Huestis; Benjamin Amendolara; Ryan Vandrey; Ziva D Cooper
Journal:  Pharmacol Biochem Behav       Date:  2020-10-18       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.